No Data
No Data
Declining Stock and Decent Financials: Is The Market Wrong About Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390)?
Guizhou Xinbang Pharmaceutical (002390.SZ): Its hospitals have testing services such as lymphocyte subgroups, cell apoptosis, and leukemia immunity analysis.
Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interactive platform that its hospital provides services such as detection of lymphocyte subgroups, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immune analysis.
Guizhou Xinbang Pharmaceutical (002390.SZ): Subsidiary pharmaceutical distribution companies have not yet engaged in self-driving delivery business.
Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform on July 18 that its pharmaceutical distribution subsidiary has not yet engaged in self-driving delivery business.
Guizhou Xinbang Pharmaceutical (002390.SZ): Its subsidiary Guizhou Guangzheng owns its own cold chain logistics vehicles and undertakes third-party warehousing and distribution business (including cold chain).
On July 12th, Gelunhui reported that Guizhou Xinbang Pharmaceutical (002390.SZ) stated on its investor interaction platform that its subsidiary, Guizhou Guangzheng Medical Logistics Co., Ltd. has its own cold chain logistics vehicle and undertakes third-party warehousing and distribution business (including cold chain).
Guizhou Xinbang Pharmaceutical (002390.SZ): Subsidiary Guizhou Haimosi Medical Co., Ltd. is involved in medical imaging cloud platform services business.
Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interactive platform that its subsidiary, Guizhou Haimosi Medical Co., Ltd., is involved in the medical cloud computing service business, which includes application services such as "image data collection and archiving management, image cloud server storage detection and operation and maintenance, mobile digital image retrieval, and image consulting diagnosis".
Guizhou Xinbang Pharmaceutical (002390.SZ): Large medical devices such as magnetic resonance imaging (MRI) devices and ultrasound equipment sold by its medical distribution subsidiaries.
Guizhou Xinbang Pharmaceutical (002390.SZ) stated on its investor interaction platform that the medical devices sold by its pharmaceutical distribution subsidiary include magnetic resonance imaging (MRI) equipment, digital angiography (DSA) equipment, digital radiography (DR) equipment, PET-CT, ultrasound equipment, and others.
No Data